Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NNMT | P40261 | 3/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28876586 | 0.82 | NNMT (0.33) | NNMTMEN1KMT2A | |
| SCHEMBL26144385 | 0.75 | NNMT (0.41) | NNMTADORA2ATDP1KMT2APOLB | |
| SCHEMBL29177275 | 0.75 | POLB (0.40) | NNMTPARP1MEN1KMT2APOLB | |
| SCHEMBL28737030 | 0.72 | NNMT (0.33) | NNMTMEN1KMT2A | |
| SCHEMBL28931441 | 0.71 | NNMT (0.45) | NNMTMEN1KMT2A | |
| SCHEMBL29150549 | 0.71 | PARP1 (0.31) | PARP1 | |
| SCHEMBL28445294 | 0.70 | MEN1 (0.40) | ADORA2APARP1MEN1KMT2A | |
| SCHEMBL28931454 | 0.69 | NNMT (0.46) | NNMTPARP1MEN1KMT2APOLB | |
| SCHEMBL28842130 | 0.69 | NNMT (0.42) | NNMTMEN1KMT2A | |
| SCHEMBL29112850 | 0.68 | NNMT (0.45) | NNMTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116888125-B | TYK2 inhibitor and application thereof | 上海齐鲁制药研究中心有限公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-116888125-A | TYK2 inhibitor and application thereof | 上海齐鲁制药研究中心有限公司 | 2023-10-13 | — | — | CN | disclosed |